Evidence check: Omega-3 Index in the context of Blutzucker

The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes and serves as a long-term marker of omega-3 status. In the context of blood sugar (glucose metabolism), the evidence is moderate: some human studies suggest that a higher Omega-3 Index is associated with improved insulin sensitivity and lower fasting glucose, particularly in individuals with metabolic syndrome or type 2 diabetes. However, other randomized controlled trials show no significant effect on glycemic control. The impact appears dose-dependent and may vary by baseline status. Importantly, the Omega-3 Index is not a direct blood sugar marker; it reflects overall inflammatory status and cardiovascular health. Raising the index through supplements does not replace standard blood sugar management via diet and exercise. Additionally, high doses of omega-3s (above 3 g/day) may increase bleeding risk, especially with anticoagulants. Consumer tests for the Omega-3 Index can be useful for assessing status, but interpretation should consider the whole clinical picture. The evidence for a direct glucose-lowering effect is not strong enough to recommend universal supplementation.